Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Cervical Cancer

  Free Subscription


07.08.2017

1 Acta Cytol
1 Am J Clin Oncol
2 Am J Obstet Gynecol
1 Asian Pac J Trop Med
1 Biomed Pharmacother
3 BMC Cancer
1 BMC Public Health
2 Brachytherapy
1 Cancer Cell Int
1 DNA Repair (Amst)
1 Gynecol Obstet Invest
1 Gynecol Oncol Rep
1 Int J Gynaecol Obstet
1 Int J Mol Sci
1 J Cell Biochem
1 J Clin Microbiol
1 J Community Health
1 J Gynecol Oncol
1 J Obstet Gynaecol Res
1 J Pak Med Assoc
1 J Pediatr Adolesc Gynecol
2 Lancet
1 Mol Med Rep
1 Molecules
1 Nutrients
3 Oncotarget
1 Ophthalmic Epidemiol
1 Phys Med
2 PLoS One
1 Postepy Hig Med Dosw (Online)
1 Prev Med
1 Protein Pept Lett
1 Virol J


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Cytol

  1. ZIEMKE P
    p16/Ki-67 Immunocytochemistry in Gynecological Cytology: Limitations in Practice.
    Acta Cytol. 2017;61:230-236.
    PubMed     Text format     Abstract available


    Am J Clin Oncol

  2. MACHIDA H, Moeini A, Ciccone MA, Mostofizadeh S, et al
    Efficacy of Modified Dose-dense Paclitaxel in Recurrent Cervical Cancer.
    Am J Clin Oncol. 2017 Jul 31. doi: 10.1097/COC.0000000000000394.
    PubMed     Text format     Abstract available


    Am J Obstet Gynecol

  3. IVERSEN L, Sivasubramaniam S, Lee AJ, Fielding S, et al
    Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners' Oral Contraception Study.
    Am J Obstet Gynecol. 2017 Feb 8. pii: S0002-9378(17)30179.
    PubMed     Text format     Abstract available

  4. DILLEY S, Scarinci I, Kimberlin D, Straughn JM Jr, et al
    Preventing HPV-Related Cancers - We Are All In This Together.
    Am J Obstet Gynecol. 2017 Feb 21. pii: S0002-9378(17)30299.
    PubMed     Text format     Abstract available


    Asian Pac J Trop Med

  5. LU Z, Chen H, Zheng XM, Chen ML, et al
    Experimental study on the apoptosis of cervical cancer Hela cells induced by juglone through c-Jun N-terminal kinase/c-Jun pathway.
    Asian Pac J Trop Med. 2017;10:572-575.
    PubMed     Text format     Abstract available


    Biomed Pharmacother

  6. MOLLAEI H, Safaralizadeh R, Babaei E, Abedini MR, et al
    The anti-proliferative and apoptotic effects of crocin on chemosensitive and chemoresistant cervical cancer cells.
    Biomed Pharmacother. 2017;94:307-316.
    PubMed     Text format     Abstract available


    BMC Cancer

  7. WANG W, Hou X, Yan J, Shen J, et al
    Outcome and toxicity of radical radiotherapy or concurrent Chemoradiotherapy for elderly cervical cancer women.
    BMC Cancer. 2017;17:510.
    PubMed     Text format     Abstract available

  8. BREBI P, Ili CG, Andana A, Menzel D, et al
    Frequency of Human papillomavirus in women attending cervical cancer screening program in Chile.
    BMC Cancer. 2017;17:518.
    PubMed     Text format     Abstract available

  9. LI J, Ning NY, Rao QX, Chen R, et al
    Pretreatment glycemic control status is an independent prognostic factor for cervical cancer patients receiving neoadjuvant chemotherapy for locally advanced disease.
    BMC Cancer. 2017;17:517.
    PubMed     Text format     Abstract available


    BMC Public Health

  10. AWUA AK, Wiredu EK, Afari EA, Tijani AS, et al
    A tailored within-community specimen collection strategy increased uptake of cervical cancer screening in a cross-sectional study in Ghana.
    BMC Public Health. 2017;18:80.
    PubMed     Text format     Abstract available


    Brachytherapy

  11. VISWANATHAN AN, Erickson BA, Ibbott GS, Small W Jr, et al
    The American College of Radiology and the American Brachytherapy Society practice parameter for the performance of low-dose-rate brachytherapy.
    Brachytherapy. 2017;16:68-74.
    PubMed     Text format     Abstract available

  12. SUNEJA G, Brown D, Chang A, Erickson B, et al
    American Brachytherapy Society: Brachytherapy treatment recommendations for locally advanced cervix cancer for low-income and middle-income countries.
    Brachytherapy. 2017;16:85-94.
    PubMed     Text format     Abstract available


    Cancer Cell Int

  13. LIU S, Liao G, Li G
    Regulatory effects of COL1A1 on apoptosis induced by radiation in cervical cancer cells.
    Cancer Cell Int. 2017;17:73.
    PubMed     Text format     Abstract available


    DNA Repair (Amst)

  14. WAGNER W, Kania KD, Ciszewski WM
    Stimulation of lactate receptor (HCAR1) affects cellular DNA repair capacity.
    DNA Repair (Amst). 2017;52:49-58.
    PubMed     Text format     Abstract available


    Gynecol Obstet Invest

  15. TYAGI N, Suneja A, Mishra K, Jain S, et al
    Comparison of Keyes Punch Biopsy Instrument with Cervical Punch Biopsy Forceps for Diagnosing Cervical Lesions.
    Gynecol Obstet Invest. 2017;82:157-162.
    PubMed     Text format     Abstract available


    Gynecol Oncol Rep

  16. WAKAYAMA A, Kudaka W, Nakasone T, Taira Y, et al
    Secondary uterine carcinosarcoma after concurrent chemoradiotherapy for cervical cancer: Case reports.
    Gynecol Oncol Rep. 2017;21:81-83.
    PubMed     Text format     Abstract available


    Int J Gynaecol Obstet

  17. MABUCHI S, Kozasa K, Kimura T
    Radical hysterectomy after radiotherapy for recurrent or persistent cervical cancer.
    Int J Gynaecol Obstet. 2017 Jul 28. doi: 10.1002/ijgo.12284.
    PubMed     Text format     Abstract available


    Int J Mol Sci

  18. HEIDEGGER H, Dietlmeier S, Ye Y, Kuhn C, et al
    The Prostaglandin EP3 Receptor Is an Independent Negative Prognostic Factor for Cervical Cancer Patients.
    Int J Mol Sci. 2017;18.
    PubMed     Text format     Abstract available


    J Cell Biochem

  19. ZENG Y, Wang KX, Xu H, Hong Y, et al
    Integrative miRNA analysis identifies hsa-miR-3154, hsa-miR-7-3, and hsa-miR-600 as potential prognostic biomarker for cervical cancer.
    J Cell Biochem. 2017 Aug 3. doi: 10.1002/jcb.26315.
    PubMed     Text format     Abstract available


    J Clin Microbiol

  20. CUSCHIERI K, Geraets D, Cuzick J, Cadman L, et al
    Performance of a cartridge based assay for the detection of clinically significant HPV infection - lessons from VALGENT (Validation of HPV Genotyping Tests).
    J Clin Microbiol. 2016 Jul 6. pii: JCM.00897.
    PubMed     Text format     Abstract available


    J Community Health

  21. HAILE ZT, Kingori C, Chavan B, Francescon J, et al
    Association Between Risky Sexual Behavior and Cervical Cancer Screening Among Women in Kenya: A Population-Based Study.
    J Community Health. 2017 Aug 3. doi: 10.1007/s10900-017-0410.
    PubMed     Text format     Abstract available


    J Gynecol Oncol

  22. HANPRASERTPONG J, Geater A, Jiamset I, Padungkul L, et al
    Fear of cancer recurrence and its predictors among cervical cancer survivors.
    J Gynecol Oncol. 2017 Jul 17. doi: 10.3802/jgo.2017.
    PubMed     Text format     Abstract available


    J Obstet Gynaecol Res

  23. PENG Y, Wang X, Feng H, Yan G, et al
    Is oral contraceptive use associated with an increased risk of cervical cancer? An evidence-based meta-analysis.
    J Obstet Gynaecol Res. 2017;43:913-922.
    PubMed     Text format     Abstract available


    J Pak Med Assoc

  24. BATOOL SA, Sajjad S, Malik H
    Cervical cancer in Pakistan: A review.
    J Pak Med Assoc. 2017;67:1074-1077.
    PubMed     Text format     Abstract available


    J Pediatr Adolesc Gynecol

  25. ROUSSOS-ROSS K, Foster L, Peterson HV, Decesare J, et al
    Do Educational Seminars for the Human Papillomavirus Vaccine Improve Attitudes Toward the Value of Vaccination?
    J Pediatr Adolesc Gynecol. 2017;30:456-459.
    PubMed     Text format     Abstract available


    Lancet

  26. TEWARI KS, Sill MW, Penson RT, Huang H, et al
    Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240).
    Lancet. 2017 Jul 27. pii: S0140-6736(17)31607.
    PubMed     Text format     Abstract available

  27. BANERJEE S
    Bevacizumab in cervical cancer: a step forward for survival.
    Lancet. 2017 Jul 27. pii: S0140-6736(17)31965.
    PubMed     Text format    


    Mol Med Rep

  28. XU L, Xu Q, Li X, Zhang X, et al
    MicroRNA-21 regulates the proliferation and apoptosis of cervical cancer cells via tumor necrosis factor-alpha.
    Mol Med Rep. 2017 Aug 2. doi: 10.3892/mmr.2017.7143.
    PubMed     Text format     Abstract available


    Molecules

  29. XU W, Mi Y, He P, He S, et al
    gamma-Tocotrienol Inhibits Proliferation and Induces Apoptosis Via the Mitochondrial Pathway in Human Cervical Cancer HeLa Cells.
    Molecules. 2017;22.
    PubMed     Text format     Abstract available


    Nutrients

  30. SALAZAR-AGUILAR S, Ruiz-Posadas LDM, Cadena-Iniguez J, Soto-Hernandez M, et al
    Sechium edule (Jacq.) Swartz, a New Cultivar with Antiproliferative Potential in a Human Cervical Cancer HeLa Cell Line.
    Nutrients. 2017;9.
    PubMed     Text format     Abstract available


    Oncotarget

  31. LIN SM, Ku HY, Chang TC, Liu TW, et al
    The prognostic impact of overall treatment time on disease outcome in uterine cervical cancer patients treated primarily with concomitant chemoradiotherapy: a nationwide Taiwanese cohort study.
    Oncotarget. 2017 Jul 27. doi: 10.18632/oncotarget.19617.
    PubMed     Text format     Abstract available

  32. KOZASA K, Mabuchi S, Komura N, Yokoi E, et al
    Comparison of clinical utilities of the platelet count and platelet-lymphocyte ratio for predicting survival in patients with cervical cancer: a single institutional study and literature review.
    Oncotarget. 2017 Jul 25. doi: 10.18632/oncotarget.19560.
    PubMed     Text format     Abstract available

  33. ZHANG J, Gao Y
    CCAT-1 promotes proliferation and inhibits apoptosis of cervical cancer cells via the Wnt signaling pathway.
    Oncotarget. 2017 Jul 10. doi: 10.18632/oncotarget.19155.
    PubMed     Text format     Abstract available


    Ophthalmic Epidemiol

  34. XU X, Mann JR, McDermott SW, Deroche CB, et al
    Women with Visual Impairment and Insured by Medicaid or Medicare Are Less Likely to Receive Recommended Screening for Breast and Cervical Cancers.
    Ophthalmic Epidemiol. 2017;24:168-173.
    PubMed     Text format     Abstract available


    Phys Med

  35. PARK JM, Park SY, Kim JI, Kang HC, et al
    A comparison of treatment plan quality between Tri-Co-60 intensity modulated radiation therapy and volumetric modulated arc therapy for cervical cancer.
    Phys Med. 2017 Jul 28. pii: S1120-1797(17)30207.
    PubMed     Text format     Abstract available


    PLoS One

  36. WANG L, Wang P, Ren Y, Du J, et al
    Prevalence of High-Risk Human Papillomavirus (HR-HPV) Genotypes and Multiple Infections in Cervical Abnormalities from Northern Xinjiang, China.
    PLoS One. 2016;11:e0160698.
    PubMed     Text format     Abstract available

  37. KHUNAMORNPONG S, Settakorn J, Sukpan K, Suprasert P, et al
    Genotyping for Human Papillomavirus (HPV) 16/18/52/58 Has a Higher Performance than HPV16/18 Genotyping in Triaging Women with Positive High-risk HPV Test in Northern Thailand.
    PLoS One. 2016;11:e0158184.
    PubMed     Text format     Abstract available


    Postepy Hig Med Dosw (Online)

  38. KALINOWSKI P, Grzadziel A
    HPV Vaccinations in Lublin Region, Poland.
    Postepy Hig Med Dosw (Online). 2017;71:92-97.
    PubMed     Text format     Abstract available


    Prev Med

  39. WATSON M, Soman A, Flagg EW, Unger E, et al
    Surveillance of high-grade cervical cancer precursors (CIN III/AIS) in four population-based cancer registries, United States, 2009-2012.
    Prev Med. 2017 Jul 29. pii: S0091-7435(17)30274.
    PubMed     Text format     Abstract available


    Protein Pept Lett

  40. TALEBI S, Bolhassani A, Azad TM, Arashkia A, et al
    Immuno-Stimulating Peptide Derived from HMGB1 is More Effective Than the N-Terminal Domain of Gp96 as an Endogenous Adjuvant for Improvement of Protein Vaccines.
    Protein Pept Lett. 2017;24:190-196.
    PubMed     Text format     Abstract available


    Virol J

  41. HAN F, Li Y, Lu Q, Ma L, et al
    3-(2-Chloropropyl amide)-4-methoxy-N-phenylbenzamide inhibits expression of HPV oncogenes in human cervical cancer cell.
    Virol J. 2017;14:145.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: